Rubicon Research IPO Allotment Status Today: Step-by-Step Guide to Check on MUFG Intime India, NSE, and BSE; GMP, Listing Date and Latest Updates

Mumbai | October 14

The ₹1,377.50-crore Rubicon Research IPO is likely to finalise its share allotment today, Tuesday, October 14, after receiving a stellar investor response with 103.90× subscription. The IPO, comprising a fresh issue of ₹500 crore and an offer-for-sale (OFS) of ₹877.50 crore by General Atlantic Singapore RR Pte Ltd, garnered strong interest across all investor categories during the three-day bidding window.

Investors who applied for the issue can check the Rubicon Research IPO allotment status through the registrar MUFG Intime India, the National Stock Exchange (NSE), or the Bombay Stock Exchange (BSE) websites by entering their application number or PAN.

Rubicon Research IPO Subscription Summary

The Rubicon Research IPO, priced in the range of ₹461–₹485 per share, was open for subscription between October 9 and October 11. According to NSE data, bids were received for 1,70,96,80,620 shares against 1,64,55,670 shares on offer, resulting in a subscription of 103.90×.

The funds raised will be utilised for repayment of borrowings, financing inorganic growth through acquisitions, and general corporate purposes.

Rubicon Research IPO Listing Date and Time

Allotment Finalisation: Tuesday, October 14, 2025
Demat Credit/Refunds: Wednesday, October 15, 2025
Listing Date: Thursday, October 16, 2025
Listing Time: 10:00 a.m.
Stock Exchanges: NSE and BSE

The Rubicon Research IPO listing is one of the most anticipated debuts of the season, backed by robust grey market sentiment and strong institutional participation.

How to Check Rubicon Research IPO Allotment Status on MUFG Intime India

Step 1- Visit the MUFG Intime India IPO allotment page – https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Step 2- Under ‘Select IPO’, choose “Rubicon Research Ltd” from the dropdown list.

Step 3- Enter your PAN, Application Number, or DP/Client ID.

Step 4- Click on ‘Submit’ to view your allotment status.

How to Check Rubicon Research IPO Allotment Status on NSE

Step 1- Visit the NSE allotment link – https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

Step 2- Choose ‘Equity & SME IPO Bid Details’.

Step 3- Select ‘RUBICON’ from the company list.

Step 4- Enter your PAN or Application Number.

Step 5- Click ‘Submit’ to view your IPO allotment details.

How to Check Rubicon Research IPO Allotment Status on BSE

Step 1- Visit the BSE allotment page- https://bseindia.com/investors/appli_check.aspx

Step 2- Under Issue Type, select ‘Equity’.

Step 3- From the dropdown, select ‘Rubicon Research Limited’ as the issue name.

Step 4- Enter your PAN or Application Number, complete the CAPTCHA, and click ‘Search’.

About Rubicon Research

Rubicon Research Limited is a pharmaceutical formulations and product development company specialising in complex generics, drug-device combinations, and specialty products targeting regulated international markets. With a focus on R&D innovation, the company aims to strengthen its footprint across North America, Europe, and emerging markets through strategic partnerships and acquisitions.

What’s Next

With the Rubicon Research IPO allotment status set to be finalised tonight, investors now await its market debut on Thursday, October 16, 2025, at 10:00 a.m. Analysts expect strong listing-day activity, mirroring robust investor sentiment and consistent demand across the pharma sector.

Rubicon Research IPO GMP Today

According to market observers, Rubicon Research shares are trading at a premium of ₹96 in the grey market, suggesting a listing gain of nearly 20% over the issue price of ₹485 per share. Reports from investorgain.com earlier pegged the unlisted share price at ₹612, implying a GMP of ₹127 (26.19%).

The strong Rubicon Research IPO GMP highlights sustained investor optimism around the company’s R&D-driven pharmaceutical portfolio, diversified customer base, and global regulatory reach.

Disclaimer: The Grey Market Premium (GMP) is an unofficial indicator of investor sentiment and is not regulated by SEBI. It should not be considered the sole basis for investment decisions.

Open a FREE Demat Account within minutes and be IPO-ready for upcoming listings!

? Join Now on PL Capital: https://www.plindia.com/